Vasundhara Rasy.

Which are the latest news on Vasundhara Rasy.?

Why is Vasundhara Rasayans Ltd falling/rising?

As of 05-Sep, Vasundhara Rasayans Ltd's stock price is at 150.55, down 4.72%, significantly underperforming the Sensex. The stock has seen a consistent decline over various time frames, with a year-to-date drop of 11.49% and a notable decrease in investor participation.

As of 05-Sep, Vasundhara Rasayans Ltd's stock price is falling, currently at 150.55, which reflects a decrease of 7.45 or 4.72%. The stock has underperformed significantly compared to the benchmark Sensex, with a performance today that is 5.18% lower than its sector. It opened the day with a loss of 3.77% and reached an intraday low of 150.25, indicating continued selling pressure.<BR><BR>Over the past week, the stock has declined by 3.49%, and over the past month, it has dropped 15.49%, which is substantially worse than the Sensex's decline of 2.44% in the same period. Year-to-date, the stock is down 11.49%, and over the past year, it has fallen 13.55%, while the Sensex has only decreased by 5.21%. The three-year performance shows a significant decline of 28.92%, contrasting sharply with the Sensex's gain of 16.59%.<BR><BR>Additionally, the stock is trading below its moving averages across various time frames (5-day, 20-day, 50-day, 100-day, and 200-day), which typically indicates a bearish trend. There has also been a notable drop in investor participation, with delivery volume falling by 83.03% against the 5-day average, suggesting reduced interest from investors. Overall, these factors contribute to the ongoing decline in the stock price of Vasundhara Rasayans Ltd.

Who are in the management team of Vasundhara Rasy.?

The management team of Vasundhara Rasy includes Rajesh Pokerna (Managing Director), Sanjoy Kumar Jain, Sunil Jain Kumar, Seema Jain, and Manish Kumar Jain (all Executive Directors), along with independent directors Pradeep Kumar Jain, Pravichandra Majumdar Popatlal, Rajiv Kakodkar, Manish Jain, and Ashish Kedia. This diverse team combines executive leadership with independent oversight.

The management team of Vasundhara Rasy includes the following individuals:<BR><BR>1. **Rajesh Pokerna** - Executive Director & Managing Director<BR>2. **Sanjoy Kumar Jain** - Executive Director & Whole-time Director<BR>3. **Sunil Jain Kumar** - Executive Director & Whole-time Director<BR>4. **Seema Jain** - Executive Director & Whole-time Director<BR>5. **Manish Kumar Jain** - Whole-time Director<BR>6. **Pradeep Kumar Jain** - Independent Non-Executive Director<BR>7. **Pravichandra Majumdar Popatlal** - Independent Non-Executive Director<BR>8. **Rajiv Kakodkar** - Independent Non-Executive Director<BR>9. **Manish Jain** - Independent Director<BR>10. **Ashish Kedia** - Independent Director<BR><BR>This team brings a mix of executive and independent oversight to the company's operations.

What does Vasundhara Rasy. do?

Vasundhara Rasayans Ltd is a Micro Cap company specializing in the manufacture and export of Antacids therapeutic category Active Pharmaceutical Ingredients. As of June 2026, it reported net sales of 7 Cr and a net profit of 1 Cr.

Overview: <BR>Vasundhara Rasayans Ltd is a leading manufacturer and exporter of Antacids therapeutic category Active Pharmaceutical Ingredients, operating within the Pharmaceuticals & Biotechnology industry and classified as a Micro Cap company.<BR><BR>History: <BR>Vasundhara Rasayans Ltd was incorporated in March 1987 and commenced operations in 1990 with an Antacid API facility. The latest quarterly results reported net sales and net profit for June 2026.<BR><BR>Financial Snapshot: <BR>Net Sales: 7 Cr (Quarterly Results - Jun 2026) <BR>Net Profit: 1 Cr (Quarterly Results - Jun 2026) <BR>Market Cap: INR 50 Cr (Micro Cap)<BR><BR>Key Metrics: <BR>P/E: 8.00 <BR>Industry P/E: 43 <BR>Dividend Yield: 2.56% <BR>Debt-Equity: -0.08 <BR>Return on Equity: 14.46% <BR>Price to Book: 1.21<BR><BR>Contact Details: <BR>Address: Shed No 42 Phase II IDA, Mallapur Hyderabad Telangana : 500076 <BR>Tel: 91-40-23437617/23437623 <BR>Email: info@vrlindia.in <BR>Website: http://www.vasundhararasayans.in

Who are the peers of the Vasundhara Rasy.?

Peers of Vasundhara Rasy. include Phaarmasia, Shelter Pharma, Biofil Chemicals, and others. Management risk varies from excellent at Shelter Pharma to below average at several peers, with Phaarmasia showing the highest 1-year return at 192.54% and Rajnish Wellness the lowest at -61.17%.

Peers: The peers of Vasundhara Rasy. are Phaarmasia, Shelter Pharma, Biofil Chemicals, Mangalam Drugs, Parmax Pharma, Kabra Drugs, Rajnish Wellness, Vivo Bio Tech, Roopa Industries, and Vilin Bio Med.<BR><BR>Quality Snapshot: Excellent management risk is observed at Shelter Pharma and Kabra Drugs, while Average management risk is found at Vasundhara Rasy., Biofil Chemicals, and Rajnish Wellness. Below Average management risk is noted at Phaarmasia, Mangalam Drugs, Parmax Pharma, Vivo Bio Tech, Roopa Industries, and Vilin Bio Med. Growth is rated as Good at Shelter Pharma and Excellent at Kabra Drugs and Roopa Industries, while Average growth is seen at Phaarmasia and Vilin Bio Med, and Below Average growth is noted at Vasundhara Rasy., Biofil Chemicals, Mangalam Drugs, Parmax Pharma, Rajnish Wellness, and Vivo Bio Tech. Capital Structure is rated as Excellent at Shelter Pharma, Good at Vasundhara Rasy. and Biofil Chemicals, and Below Average at Phaarmasia, Mangalam Drugs, Parmax Pharma, Kabra Drugs, Rajnish Wellness, Vivo Bio Tech, Roopa Industries, and Vilin Bio Med.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Phaarmasia at 192.54%, while the lowest is Rajnish Wellness at -61.17%, with Vasundhara Rasy. having a 1-year return of -14.57%. Additionally, the peers with negative six-month returns include Shelter Pharma, Kabra Drugs, Rajnish Wellness, Vivo Bio Tech, and Roopa Industries.

How big is Vasundhara Rasy.?

As of 31st August, Vasundhara Rasayans Ltd has a market capitalization of 50.00 Cr, with recent Net Sales of 35.09 Cr and a Net Profit of 5.91 Cr. Shareholder's Funds are 40.88 Cr and Total Assets are 47.88 Cr as of March 2026.

As of 31st August, Vasundhara Rasayans Ltd has a market capitalization of 50.00 Cr, categorizing it as a Micro Cap company.<BR><BR>In the latest four quarters, the company reported Net Sales of 35.09 Cr and a Net Profit of 5.91 Cr.<BR><BR>For the latest annual period ending in March 2026, Shareholder's Funds amounted to 40.88 Cr, while Total Assets were reported at 47.88 Cr.

Should I buy, sell or hold Vasundhara Rasayans Ltd?

When is the next results date for Vasundhara Rasayans Ltd?

The next results date for Vasundhara Rasayans Ltd is 14 August 2026.

The next results date for Vasundhara Rasayans Ltd is scheduled for 14 August 2026.

Are Vasundhara Rasayans Ltd latest results good or bad?

Vasundhara Rasayans Ltd's latest results show strong profit growth with a 261.40% increase in net profit to ₹2.06 crores and an improved operating margin of 24.04%. However, revenue declined by 9.82% year-on-year to ₹8.82 crores, indicating challenges despite the positive profit performance.

The latest results for Vasundhara Rasayans Ltd present a mixed picture. On one hand, the company reported a significant increase in net profit for Q2 FY26, reaching ₹2.06 crores, which is a remarkable 261.40% increase quarter-on-quarter. This improvement is accompanied by a strong operating margin of 24.04%, a substantial rise from just 4.23% in the previous quarter. <BR><BR>However, the revenue figures tell a different story. The company generated ₹8.82 crores in revenue for Q2 FY26, which represents a 9.82% decline compared to the same quarter last year. While there was a sequential growth of 16.67% from the previous quarter, the year-on-year drop raises concerns about the sustainability of this growth.<BR><BR>Overall, while the profit margins and operational efficiency have improved significantly, the decline in revenue indicates underlying challenges that the company faces. This combination of strong profit growth alongside stagnating revenue suggests that while there are positive aspects, there are also serious concerns that need to be addressed. Therefore, the results can be seen as good in terms of profitability but bad in terms of revenue growth, reflecting a complex situation for the company.

Is Vasundhara Rasy. overvalued or undervalued?

As of December 4, 2025, Vasundhara Rasy. is considered overvalued with a valuation grade of "expensive," a PE Ratio of 13.42, and a year-to-date return of -35.36%, significantly lagging behind its peers and the Sensex.

As of 4 December 2025, the valuation grade for Vasundhara Rasy. has moved from very expensive to expensive, indicating a shift in perception regarding its market valuation. The company is currently considered overvalued. Key ratios include a PE Ratio of 13.42, an EV to EBITDA of 14.79, and a ROE of 12.74%. <BR><BR>In comparison to peers, Vasundhara Rasy.'s PE Ratio is significantly lower than Solar Industries, which has a PE of 88.66, and Gujarat Fluoroch at 54.14. While Vasundhara Rasy. shows a PEG Ratio of 0.00, indicating no growth expectations, its current valuation does not align favorably with its peers in the Pharmaceuticals & Biotechnology sector. Additionally, the company's recent stock performance has lagged behind the Sensex, with a year-to-date return of -35.36% compared to the Sensex's 9.12%, further reinforcing the overvaluation narrative.

How has been the historical performance of Vasundhara Rasy.?

Vasundhara Rasy has experienced fluctuating net sales and profits, peaking at 37.94 Cr in Mar'23 but declining to 33.99 Cr by Mar'25, alongside a decrease in profitability and negative cash flow trends. Despite an increase in total assets and liabilities, the company's operating profit margin and overall profitability have faced significant challenges.

Answer:<BR>The historical performance of Vasundhara Rasy shows a fluctuating trend in net sales and profits over the years, with a notable decline in recent periods.<BR><BR>Breakdown:<BR>Vasundhara Rasy's net sales peaked at 37.94 Cr in Mar'23 but fell to 33.99 Cr by Mar'25. The total operating income followed a similar trend, decreasing from 37.94 Cr in Mar'23 to 33.99 Cr in Mar'25. The raw material costs have remained relatively stable, with a slight increase from 15.53 Cr in Mar'24 to 15.63 Cr in Mar'25. Operating profit (PBDIT) also declined from 8.33 Cr in Mar'24 to 6.40 Cr in Mar'25, reflecting a decrease in operating profit margin from 17.26% to 11.92%. Profit before tax decreased from 7.90 Cr in Mar'24 to 5.77 Cr in Mar'25, while profit after tax dropped from 5.86 Cr to 4.25 Cr in the same period. The company's total assets increased from 37.30 Cr in Mar'24 to 43.07 Cr in Mar'25, alongside a rise in total liabilities from 37.30 Cr to 43.07 Cr. Cash flow from operating activities showed a negative trend, with a cash outflow of 5.00 Cr in Mar'25 compared to an inflow of 6.00 Cr in Mar'24. Overall, while Vasundhara Rasy has seen growth in total assets, its profitability and cash flow have faced challenges in recent years.

What is the technical trend for Vasundhara Rasy.?

As of May 23, 2025, Vasundhara Rasy's technical trend has shifted to a moderate bearish stance, supported by bearish signals from key indicators like the MACD, Bollinger Bands, and moving averages, along with significant underperformance compared to the Sensex.

As of 23 May 2025, the technical trend for Vasundhara Rasy has changed from mildly bearish to bearish. The current stance is bearish with a moderate strength. Key indicators driving this assessment include the weekly MACD and Bollinger Bands both indicating bearish conditions, along with daily moving averages also showing bearish signals. The KST is bearish on a weekly basis and mildly bearish monthly, while Dow Theory reflects a mildly bearish stance on the weekly and monthly time frames. The stock has underperformed significantly compared to the Sensex over various periods, particularly year-to-date and over the past year.

Who are the top shareholders of the Vasundhara Rasy.?

The top shareholder of Vasundhara Rasy is P & J Cretechem Private Limited, holding 61.98%, followed by Garg Leasing And Finance Private Limited at 3.55%, while individual investors own 30.05%. There are no mutual funds or foreign institutional investors in the company.

The top shareholders of Vasundhara Rasy include P & J Cretechem Private Limited, which holds the largest stake at 61.98%. The highest public shareholder is Garg Leasing And Finance Private Limited, with a holding of 3.55%. Additionally, individual investors collectively own 30.05% of the company. There are no mutual funds or foreign institutional investors currently holding shares in Vasundhara Rasy.

Has Vasundhara Rasy. declared dividend?

Vasundhara Rasayans Ltd has declared a 20% dividend, amounting to ₹2 per share, with an ex-date of September 23, 2024. While the stock has shown strong long-term gains, recent performance reflects negative returns in the short term, and the dividend yield is relatively low at 0.98%.

Vasundhara Rasayans Ltd has declared a 20% dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 20%<BR>- Amount per share: 2<BR>- Ex-date: 23 Sep 24<BR><BR>Dividend Yield: 0.98%.<BR><BR>Total Returns by Period:<BR>In the last 6 months, the price return was -27.93%, with a dividend return of 0%, resulting in a total return of -27.93%.<BR><BR>Over the past year, the price return was -7.7%, the dividend return was 0.87%, leading to a total return of -6.83%.<BR><BR>In the 2-year period, the price return was 30.53%, the dividend return was 2.57%, culminating in a total return of 33.1%.<BR><BR>During the last 3 years, the price return was 77.1%, with a dividend return of 4.75%, resulting in a total return of 81.85%.<BR><BR>For the 4-year period, the price return was 112.13%, the dividend return was 5.39%, which led to a total return of 117.52%.<BR><BR>In the 5-year span, the price return was 479.66%, with a dividend return of 16.81%, resulting in a total return of 496.47%.<BR><BR>Overall, while Vasundhara Rasayans Ltd has declared a dividend, the recent total returns indicate a mixed performance, with significant gains over longer periods but negative returns in the short term. The dividend yield is relatively low, suggesting that while dividends are being paid, the stock may not be performing strongly in the short run.